These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10488328)

  • 1. [The therapy of acute myeloid leukemia in patients of advanced age].
    Kern W; Schoch C; Fonatsch C; Heinecke A; Wörmann B; Büchner T; Hiddemann W
    Dtsch Med Wochenschr; 1999 Aug; 124(34-35):1005-14. PubMed ID: 10488328
    [No Abstract]   [Full Text] [Related]  

  • 2. The approach to the elderly patient with acute myeloid leukemia.
    Stone RM; Mayer RJ
    Hematol Oncol Clin North Am; 1993 Feb; 7(1):65-79. PubMed ID: 7680642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of survival. Chemotherapeutically treated and untreated older patient with acute myeloid leukemia.
    Siddiqui T; Durkin WJ; Conley NS; Doughney KB; Favis GR; Weiss R; Smith AE
    J Fla Med Assoc; 1994 Jul; 81(7):475-7. PubMed ID: 7964574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnostics and therapy of acute myeloid leukemia].
    Fritsch S; Metzeler K; Hiddemann W; Buske C
    Dtsch Med Wochenschr; 2006 Oct; 131(43):2401-6. PubMed ID: 17054056
    [No Abstract]   [Full Text] [Related]  

  • 5. [Acute leukemia: which of two types of cell death (necrosis or apoptosis) may be responsible for patients' death during intensive chemotherapy?].
    Petukhov VI; Pavlov BN
    Ter Arkh; 2002; 74(12):100-4. PubMed ID: 12577856
    [No Abstract]   [Full Text] [Related]  

  • 6. The outcome of intensive induction therapy in patients >or=70 years with acute myeloid leukemia.
    Gupta V; Xu W; Keng C; Alibhai SM; Brandwein J; Schimmer A; Schuh A; Yee K; Minden MD
    Leukemia; 2007 Jun; 21(6):1321-4. PubMed ID: 17344911
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of the newly diagnosed adult with de novo acute myeloid leukemia.
    Stone RM; Mayer RJ
    Hematol Oncol Clin North Am; 1993 Feb; 7(1):47-64. PubMed ID: 8449864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Elderly patients with acute myeloid leukemia: characteristics in biology, patients, and treatment].
    Wedding U; Bokemeyer C; Meran JG; ; ;
    Med Klin (Munich); 2003 Apr; 98(4):193-207. PubMed ID: 12715143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute myeloid leukemia treatment in patients over 60 years of age. Comparison of symptomatic, palliative, and aggressive therapy.
    Doubek M; Palasek I; Brychtova Y; Buchtova I; Mayer J
    Neoplasma; 2005; 52(5):411-4. PubMed ID: 16151586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The current chemotherapy of acute myeloid leukemias in adults].
    Poddubnaia IV; Perilov AA
    Ter Arkh; 1993; 65(7):86-9. PubMed ID: 8211791
    [No Abstract]   [Full Text] [Related]  

  • 11. Special clinical concerns/problems in the management of MDS and secondary acute myeloid leukemias.
    Venugopal P; Manson S; Preisler HD
    Cancer Treat Res; 2001; 108():257-65. PubMed ID: 11702603
    [No Abstract]   [Full Text] [Related]  

  • 12. Prognosis of older patients with acute myeloid leukemia receiving either induction or noncurative treatment: a single-center retrospective study.
    Behringer B; Pitako JA; Kunzmann R; Schmoor C; Behringer D; Mertelsmann R; Lübbert M
    Ann Hematol; 2003 Jul; 82(7):381-9. PubMed ID: 12756497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "3+7" therapy for the treatment of acute myeloid leukemia. CON.
    Estey EH
    Clin Adv Hematol Oncol; 2005 Feb; 3(2):129-132, 141. PubMed ID: 16173152
    [No Abstract]   [Full Text] [Related]  

  • 14. New agents in the treatment of acute myeloid leukemia.
    Wiernik PH
    Semin Hematol; 1991 Jul; 28(3 Suppl 4):95-8. PubMed ID: 1780763
    [No Abstract]   [Full Text] [Related]  

  • 15. [The therapeutic results in acute myeloid leukemias in elderly patients].
    Parovichnikova EN; Savchenko VG; Isaev VG; Tikhonova LIu; Sarycheva TG; Kulikov SM
    Ter Arkh; 1992; 64(8):87-9. PubMed ID: 1440406
    [No Abstract]   [Full Text] [Related]  

  • 16. Strategies other than dose-intensification should be pursued in elderly patients with untreated acute myeloblastic leukemia.
    Haematologica; 2002 Aug; 87(8):786. PubMed ID: 12161350
    [No Abstract]   [Full Text] [Related]  

  • 17. Multivariate analyses of prognostic factors in acute myeloid leukemia: relevance of cytogenetic abnormalities and CD34 expression.
    Junghanss C; Waak M; Knopp A; Kleine HD; Kundt G; Leithäuser M; Hilgendorf I; Wolff D; Casper J; Freund M
    Neoplasma; 2005; 52(5):402-10. PubMed ID: 16151585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intensive chemotherapy with idarubicin, cytarabine, etoposide, and G-CSF priming in patients with advanced myelodysplastic syndrome and high-risk acute myeloid leukemia.
    Hofmann WK; Heil G; Zander C; Wiebe S; Ottmann OG; Bergmann L; Hoeffken K; Fischer JT; Knuth A; Kolbe K; Schmoll HJ; Langer W; Westerhausen M; Koelbel CB; Hoelzer D; Ganser A
    Ann Hematol; 2004 Aug; 83(8):498-503. PubMed ID: 15156346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapy of acute myeloid leukemia in children.
    Nesbit ME; Woods WG
    Leukemia; 1992; 6 Suppl 2():31-5. PubMed ID: 1578938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of remission induction chemotherapy on survival in older adults with acute myeloid leukemia.
    Baz R; Rodriguez C; Fu AZ; Jawde RA; Kalaycio M; Advani A; Sobecks R; Sekeres MA
    Cancer; 2007 Oct; 110(8):1752-9. PubMed ID: 17724726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.